| The complex relationship between body mass index and response to immune checkpoint inhibition in metastatic melanoma patients D Donnelly, S Bajaj, J Yu, M Hsu, A Balar, A Pavlick, J Weber, I Osman, ... Journal for immunotherapy of cancer 7, 1-8, 2019 | 84 | 2019 |
| Baseline prognostic nutritional index and changes in pretreatment body mass index associate with immunotherapy response in patients with advanced cancer P Johannet, A Sawyers, Y Qian, S Kozloff, N Gulati, D Donnelly, J Zhong, ... Journal for ImmunoTherapy of Cancer 8 (2), 2020 | 65 | 2020 |
| Melanoma prognosis: accuracy of the American Joint Committee on cancer staging manual eighth edition S Bajaj, D Donnelly, M Call, P Johannet, U Moran, D Polsky, R Shapiro, ... JNCI: Journal of the National Cancer Institute 112 (9), 921-928, 2020 | 45 | 2020 |
| A deep learning approach for rapid mutational screening in melanoma RH Kim, S Nomikou, N Coudray, G Jour, Z Dawood, R Hong, E Esteva, ... BioRxiv, 610311, 2019 | 42 | 2019 |
| The “-OMICS” facet of melanoma: Heterogeneity of genomic, proteomic and metabolomic biomarkers D Donnelly III, PP Aung, G Jour Seminars in cancer biology 59, 165-174, 2019 | 33 | 2019 |
| Deep learning and pathomics analyses reveal cell nuclei as important features for mutation prediction of BRAF-mutated melanomas RH Kim, S Nomikou, N Coudray, G Jour, Z Dawood, R Hong, E Esteva, ... Journal of Investigative Dermatology 142 (6), 1650-1658. e6, 2022 | 24 | 2022 |
| Revisiting the association between skin toxicity and better response in advanced cancer patients treated with immune checkpoint inhibitors N Gulati, D Donnelly, Y Qian, U Moran, P Johannet, J Zhong, I Osman Journal of Translational Medicine 18, 1-6, 2020 | 15 | 2020 |
| The urgency of utilizing COVID-19 biospecimens for research in the heart of the global pandemic I Osman, P Cotzia, U Moran, D Donnelly, C Arguelles-Grande, S Mendoza, ... Journal of Translational Medicine 18, 1-4, 2020 | 14 | 2020 |
| Treatment with therapeutic anticoagulation is not associated with immunotherapy response in advanced cancer patients P Johannet, A Sawyers, N Gulati, D Donnelly, S Kozloff, Y Qian, ... Journal of Translational Medicine 19, 1-7, 2021 | 10 | 2021 |
| Genomic and transcriptomic analyses of NF1-mutant melanoma identify potential targeted approach for treatment G Jour, I Illa-Bochaca, M Ibrahim, D Donnelly, K Zhu, EVS de Miera, ... Journal of Investigative Dermatology 143 (3), 444-455. e8, 2023 | 7 | 2023 |
| The relationship between obesity and immunotherapy: It's complicated. DMA Donnelly, S Bajaj, J Zhong, JS Weber, AC Pavlick, AV Balar, M Hsu, ... Journal of Clinical Oncology 37 (15_suppl), 9562-9562, 2019 | 6 | 2019 |
| Using machine learning algorithms to predict response and toxicity to immune checkpoint inhibitors (ICIs) in melanoma patients. P Johannet, N Coudray, G Jour, DMA Donnelly, S Bajaj, U Moran, ... Journal of Clinical Oncology 37 (15_suppl), 2581-2581, 2019 | 3 | 2019 |
| Using machine learning to predict immunotherapy response in advanced melanoma. P Johannet, N Coudray, DM Donnelly, G Jour, I Illa-Bochaca, Y Xia, ... Journal of Clinical Oncology 38 (15_suppl), 10010-10010, 2020 | 2 | 2020 |
| Lack of evidence to support large-panel genomic testing in treatment selection for malignant melanoma. M Dimitrova, MJ Kim, DM Donnelly, KM Giles, U Moran, JS Weber, ... Journal of Clinical Oncology 38 (15_suppl), e22027-e22027, 2020 | 1 | 2020 |
| Design of a Decision Support Interface for an Intelligent Cockpit Assistant D Donnelly, D Johnson, J Noyes REPORT-UNIVERSITY OF BRISTOL DEPARTMENT OF AEROSPACE ENGINEERING, 1997 | 1 | 1997 |
| The urgency of utilizing COVID-19 biospecimens for research in the heart of the global pandemic (vol 18, 219, 2020) I Osman, P Cotzia, U Moran, D Donnelly, C Arguelles-Grande, S Mendoza, ... JOURNAL OF TRANSLATIONAL MEDICINE 19 (1), 2021 | | 2021 |
| Correction to: The urgency of utilizing COVID-19 biospecimens for research in the heart of the global pandemic I Osman, P Cotzia, U Moran, D Donnelly, C Arguelles-Grande, S Mendoza, ... Journal of Translational Medicine 19, 2021 | | 2021 |
| CDC20 is a novel potential therapeutic target in NF1-mutant melanoma. DM Donnelly, KM Giles, E Vega-Saenz de Miera, R Betensky, C Winskill, ... Journal of Clinical Oncology 38 (15_suppl), e22075-e22075, 2020 | | 2020 |
| Effect of administration of systemic steroids on survival benefit associated with immunotherapy-induced skin toxicity. N Gulati, DM Donnelly, Y Qian, U Moran, P Johannet, AC Pavlick, J Zhong, ... Journal of Clinical Oncology 38 (15_suppl), e22046-e22046, 2020 | | 2020 |
| Tumor Microenvironment Characteristics in Early and Advanced TERT Promoter Hotspot Mutant Melanomas I Hindi, D Donnelly, S Kelly, R Berman, EVS de Miera, A Pavlick, I Osman, ... LABORATORY INVESTIGATION 100 (SUPPL 1), 468-470, 2020 | | 2020 |
